Exploring Hallucinogens: Mind-Altering Realities and Approaches to Testing

In this insightful live recorded webinar, we delve into the world of hallucinogens from a point of care toxicology testing standpoint. We will explore various types of hallucinogens, their effects on the mind and body, and the challenges they present in regard to toxicology screening. Our Chief Product Officer, Eric Malis, will discuss current testing methods, limitations, and future advancements in this field. Whether you’re a healthcare professional, researcher, or simply have an interest in the subject, this webinar promises to provide valuable knowledge and perspective.

Opiates and Opioids: Breaking Down the Differences

Chief Product Officer, Eric Malis, discusses Opiates and Opioids and the differences between them. Often the two are thought to be one in the same but there is important information you need to know about what makes them different and what that means from a drug testing stand point.

Benzodiazepine: Important Information About the Often-Abused Depressant

Xylazine: An Emerging Threat and What You Need to Know

Fine Print to Clarity: Critical Information You Need to Know from Product Inserts

State of Designer Opioids